The 19th National Life Science & Technology Week May 11-13, 2021 | Digital Event, Israel

MIXiii Biomed 2021 Agenda

LIVE PLENARY SESSIONS

LIVE PLENARY SESSIONS

(Israel Time)MAY 11
4:00 pm – 4:15 pm

Welcome by Conference Chairpersons

Ruti Alon, Ora Dar, Nissim Darvish

4:15 pm – 4:55 pm

Francois Maisonrouge, Senior Managing Director in Evercore’s Advisory business

“Fifteen Months into the Pandemic; Four Months into the Biden Administration

What Have we Learned?  What can we Expect?  What Should we do?”

 

4:55 pm – 5:35 pm

Liz Barrett, President and Chief Executive Officer, UroGen Pharma

“Multi Factorial Approaches to Treating Oncological Diseases”

 

5:35 pm – 6:15 pm  

Prof. Ronni GamzuM.D., Ph.D., Chief Executive Officer, Tel Aviv Sourasky Medical    Center

Post Covid Techceleration

(Israel Time)

MAY 12

4:00 pm – 4:40 pm

Barry Greene, Chief Executive Officer and Member of Board of Directors, Sage Therapeutics

                     “Is There More to Discover in the Brain than on the Moon?”

4:40 pm – 5:20 pm

Dr. John Halamka, President of Mayo Clinic Platform, Mayo Clinic

“The Digital Reconstruction of Healthcare           

 

 5:20 pm – 6:00 pm   

Dr. Jeremy Levin, Chairman and Chief Executive Officer, Ovid Therapeutics Inc.

“Politics, Science, and Medicine do not Mix”

(Israel Time)

MAY 13

4:00 pm–4:40 pm

Robert C. Cohen, President, Digital, Robotics, and Enabling Technologies, Stryker Corp.

“Technology Benefiting Orthopedic Device Innovation”

4:40 pm – 5:00 pm

Anya Eldan, Vice President, Israel Innovation Authority and Head of Startup Division

Prof. Rivka CarmiM.D., ex. President of Ben Gurion University, Chairwoman of Telem National Committee of Bio Conversion

“BioConvergence – Building Medicine of the Future”

 

 5:00 pm – 5:20 pm  

Dr. Orna Berry,

Entrepreneur, Scientist and Industry Executive 

The AI and Data Science National Committee Initiatives for Health and Medical Fields

 

 5.20 pm – 6.00 pm

TBA

DETAILED AGENDA

May 11th

09:00-11:00 || Exhibition Networking Hours

11:00-16:00 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry

16:00-16:15 || Welcome by Conference Chairpersons

16:15-16:55 ||Francois Maisonrouge, Senior Managing Director in Evercore’s Advisory business –  “Fifteen Months into the Pandemic; Four Months into the Biden Administration

What Have we Learned?  What can we Expect?  What Should we do?

16:55-17:35 || Liz Barrett, President and Chief Executive Officer, UroGen Pharma – Multi Factorial Approaches to Treating Oncological Diseases    

17:35-18:15 ||Prof. Ronni Gamzu, M.D., Ph.D., Chief Executive Officer, Tel Aviv Sourasky Medical Center –Post Covid Techceleration

18:15-19:00 || Latham & Watkins – The Biden Administration: A Snapshot of FDA and CMS Policy Priorities for Life Science Companies

Stuart Kurlander, Global Co-chair of the Israel Practice and Healthcare & Life Sciences Partner, Latham & Watkins

Ben Hass, Healthcare & Life Sciences Partner, Latham & Watkins

Chris Schott, Healthcare & Life Sciences Partner, Latham & Watkins

Elizabeth Richards, Healthcare & Life Sciences Partner, Latham & Watkins

John Whyte, Chief Medical Officer, WebMD

Stephen Ubl, President and CEO, Pharmaceutical Research and Manufacturers of America (PhRMA)

Sarah Pitluck, Head of Global Pricing & Reimbursement, Spark Therapeutics

19:00pm-19:45pm || OLYMPUS Corporation – Introduction of Olympus

19:45pm -20:30pm || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry15

May 12th  

09:00-11:00 || Exhibition Networking Hours

11:00-15:15 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry

15:15-16:00||Deloitte Panel – Next-Gen Therapies

Moderator: Arod Balissa, Deloitte Catalyst Tel-Aviv

Amit Agarwal, Managing Director, NextGen Therapies Deloitte Consulting

Arturo Araya, Chief Commercial Officer, Trakcel

Meredith Unger, Director of Marketing Cell therapy, Janssen (J&J)

Michael Mullette, VP Managing Director North America, Moderna 

16:00-16:40 ||Barry Greene, Chief Executive Officer and Member of Board of Directors, Sage Therapeutics – Is There More to Discover in the Brain than on the Moon?

16:40-17:20 ||Dr. John Halamka, President of Mayo Clinic Platform, Mayo Clinic – The Digital Reconstruction of Healthcare

17:20-18:00 ||Dr. Jeremy Levin, Chairman and Chief Executive Officer, Ovid Therapeutics Inc. –  Politics, Science, and Medicine do not Mix

18:00-18:45 |Hogan Lovells Panel – Medical Device and Technology Regulatory Landscape Overview and Trends Shaping the Future

Jonathan Kahan, Partner, Hogan Lovells

John Smith, Partner, Hogan Lovells

Stuart Langbein, Partner, Hogan Lovells

Randy Prebula, Partner, Hogan Lovells

18:45 -19:30 || Covington – Innovating with AI/ML: Ethical, Legal, and Regulatory Considerations

Wade Ackerman, Partner, Covington

David Wildman, Associate, Covington

19:30-20:00 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry

May 13th  

09:00-11:00 || Exhibition Networking Hours

11:00-15:15 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry

15:15-16:00 || Medison Ventures Panel – Post Pandemic – A window to Digital Neuro Transformation

Thibaud Guymard, Sr. Director, Global Innovation Officer & Konectom General Manager, BHS at Biogen

Professor Gal Ifergane, Chairman of the Division of Brain Medicine at Soroka Medical Center

Dr. Tracy Dennis-Tiwary, CEO, Wise Therapeutics

Dr. Shiri Ron, Analyst, Neurology at Medison Ventures

Dr. Itsik Francis, Manager, Strategic Alliances & innovation at Medison Ventures

16:00-16:40 ||Robert C. Cohen, President, Digital, Robotics, and Enabling Technologies, Stryker Corp.Technology Benefiting Orthopedic Device Innovation

16:40-17:00 ||Israel Innovation Authority – BioConvergence – Building Medicine of the Future:

Anya Eldan, Vice President, Israel Innovation Authority and Head of Startup Division

Prof. Rivka Carmi, M.D., ex. President of Ben Gurion University, Chairwoman of Telem National Committee of Bio Conversion

Fire Chat – Role of Bioconversion in Future therapeutic Solutions

17:00-17:20 ||Dr. Orna Berry, Entrepreneur, Scientist and Industry Executive – The AI and Data Science National Committee Initiatives for Health and Medical Fields

17:20-18:00 ||TBA

18:00-18:45 || Deloitte Panel – Future of Trust

Michael Bondar, Principal at Deloitte US and Future of Trust Leader

18:45-20:00 || Video Playlist On Demand – Company Presentations: Best of Start-Ups and Technologies in the Industry